Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background and Aims: This updated meta-analysis aimed to further quantify the risk of endometrial, ovarian, and breast cancer in patients with polycystic ovary syndrome (PCOS), thus providing updated and more reliable estimates. Methods and Results: We identified relevant articles by searching electronic databases of PubMed, Embase, Web of Science, and Chinese Biological Medical Literature (CBM) published up to March 20, 2021. The pooled effect estimates and their 95% confidence intervals ( CIs) were calculated using the random-effect model or the fixed-effect model. A total of 26 eligible studies were included. We found that PCOS was significantly associated with endometrial cancer (odds ratios [ OR]: 3.66, 95% CI: 2.05–6.54, P < 0.001), but not with ovarian or breast cancer ( OR: 1.23, 95% CI: 0.99–1.53, P = 0.059; OR: 0.94, 95% CI: 0.78–1.14, P = 0.551, respectively). However, in subgroups of high-quality studies, cohort studies, younger women (54 years or less or premenopausal), and studies with unadjusted body mass index (BMI), PCOS patients had a significantly higher risk of ovarian cancer. Conclusion: These results indicated that PCOS is a significant risk factor for endometrial cancer independent of BMI, but not for breast cancer. PCOS may increase the risk of ovarian cancer in younger women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of endometrial cancer has been reported to be increased 3-5 fold in those with PCOS in the postmenopause years, and an increased risk for ovarian cancer has been reported in younger women with PCOS in the premenopause years.6,123, 124, 125”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [124]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“Cochran’s Q statistic and the I(2) test were used to evaluate heterogeneity.(13) The value of I(2)>50% or P< 0.”
MethodOperating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
A basic introduction to fixed-effect and random-effects models for meta-analysis
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2010) · Research Synthesis Methods · doi:10.1002/jrsm.12 · Cited by 6,793 · cited 1×
“If there was heterogeneity, the random effect model was utilized; otherwise, the fixed effect model was adopted.(14) We performed the sensitivity analysis by omitting each study to evaluate the stability and liability of the overall results.”
MethodQUANTITATIVE METHODS IN THE REVIEW OF EPIDEMIOLOGIC LITERATURE1
GREENLAND, S. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036298 · Cited by 1,644 · cited 1×
“Since cancer is relatively rare in PCOS patients, differences betweenHR, RR, andOR can generally be ignored.(12) Cochran’s Q statistic and the I(2) test were used to evaluate heterogeneity.”
MethodTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · cited 1×
“PCOS patients often accompany a broad spectrum of complications and comorbidities, including reproductive, metabolic, psychological, and other aspects,(2) and thus exert complex implications across the lifespan.(3) The irregular hormonal and metabolic conditions of PCOS women may increase the risk of certain cancers.”
Barry, J. A., Azizia, M. M., & Hardiman, P. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu012 · Cited by 597 · cited 5×
“In 2014, Barry et al.8 ruled out studies with exposure to PCO and further evaluated the association between PCOS and endometrial (5 studies), ovarian (3 studies), and breast (3 studies) cancer within 11 studies.”
BackgroundInfluentialAzziz, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002698 · Cited by 573
Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
Barber, T. M., Hanson, P., Weickert, M. O., & Franks, S. (2019) · Clinical Medicine Insights: Reproductive Health · doi:10.1177/1179558119874042 · Cited by 411 · cited 1×
“PCOS is a disease related to obesity.(42) In particular, obesity is also strongly associated with endocrine cancer.”
BackgroundEndometrial function in women with polycystic ovary syndrome: a comprehensive review
Palomba, S., Piltonen, T. T., & Giudice, L. C. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa051 · Cited by 372 · cited 5×
“It should be noted that one article included nine case-control studies investigating the association between invasive ovarian cancer and self-reported PCOS.32 Since two of them were repeated with other studies we have already included,24, 30 we extracted seven of them from this article.”
BackgroundInfluential
Research works printed but not linked: 9
- Escobedo LG, 1991, Obstet Gynecol, 77, 124
- Niwa K, 2000, Oncol Rep, 7, 89
- Iatrakis G, 2006, Eur J Gynaecol Oncol, 27, 399
- Ghasemi N, 2010, Iran J Reprod Med, 8, 86
- Cen L, 2012, Chinese Journal of Clinical Medicine, 19, 511
- Weng Q, 2012, Article in Chinese] Journal of Chinese Oncology, 18, 456
- Ma C, 2015, Journal of Taishan Medical College, 36, 944
- Speert H, 1949, Surg Gynecol Obstet, 88, 332
- Coulam CB, 1983, Obstet Gynecol, 61, 403
Cited by
Vine, D., Ghosh, M., Wang, T., & Bakal, J. (2024) · CJC Open · doi:10.1016/j.cjco.2023.12.010 · Cited by 53
Establishing a Gold Standard for Quantitative Menstrual Cycle Monitoring
Bouchard, T. P., Yong, P. J., & Doyle–Baker, P. K. (2023) · Medicina · doi:10.3390/medicina59091513 · Cited by 37
“Medical Art (smart.servier.com, accessed on 1 October 2022).”
Jung, W., Choi, H., Kim, J., Kim, J., Kim, W., Nurkolis, F., & Kim, B. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20889 · Cited by 36
“Furthermore, PCOS has been considered to be a risk factor for cardiometabolic diseases such as type 2 diabetes, myocardial infarction, and stroke, and PCOS may increase the risk of ovarian cancer in younger women [4,5].”
BackgroundPolycystic ovary syndrome and adipose tissue
Lemaître, M., Christin‐Maître, S., & Kerlan, V. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.11.004 · Cited by 40
Park‐Simon, T., Müller, V., Jackisch, C., Albert, U., Banys-Paluchowski, M. J., Bauerfeind, I., Blohmer, J., Budach, W., Dall, P., Ditsch, N., et al. (2023) · Breast Care · doi:10.1159/000531578 · Cited by 31
“PCO syndrome may possibly have an unfavorable impact (LoE3b/C) [4], whereas assisted reproduction (LoE2b/B), and abortion (LoE2b/B) do not in fl uence the risk for BC.”
Metadata
- Authors
- Li, Z., Wang, Y.-H., Wang, L.-L., Hu, D.-T., Teng, Y., Zhang, T.-Y., Yan, Z.-Y., Wang, F., & Zou, Y.-F.
- Affiliations
- Anhui Medical University (CN)
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, Anhui, China
- Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui, China
- First Affiliated Hospital of Anhui Medical University (CN)
- Corresponding author
- Li, Zhen
- Venue
- Scottish Medical Journal
- Publisher
- SAGE Publications
- Published
- 2022-06-09
- Volume
- 67
- Issue
- 3
- Pages
- 109-120
- ISSN
- 0036-9330 (ISSN-L)
- 2045-6441
- OpenAlex
- W4281646126
- Cited by
- 40
- References
- 38
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 9 · 2023: 8 · 2022: 2
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Scottish Medical Journal (publishedVersion)
- PubMed (publishedVersion)
- TigerPrints (Clemson University) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81673254, 81872683)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- polycystic ovary syndrome, endometrial cancer, ovarian cancer, breast cancer, cancer risk, body mass index, premenopausal women, risk factors
- MeSH terms
- Breast Neoplasms, Female, Humans, Ovarian Neoplasms, Polycystic Ovary Syndrome, Risk Factors, Endometrial Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis. https://app.cochat.ai/papers/10.1177/00369330221107099
- The paper
- Li, Z., Wang, Y.-H., Wang, L.-L., Hu, D.-T., Teng, Y., Zhang, T.-Y., Yan, Z.-Y., Wang, F., & Zou, Y.-F. (2022). Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis. Scottish Medical Journal. https://doi.org/10.1177/00369330221107099
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.